Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Patient safety

Fatal case of progressive multifocal leukoencephalopathy linked to Tecfidera

A fatal case of progressive multifocal leukoencephalopathy (PML) has been reported for the first time in a patient receiving dimethyl fumarate (Tecfidera), a medicine that was recently launched for relapsing-remitting multiple sclerosis (MS).

PML is a viral infection of the brain. The virus is carried by most healthy people but when the immune system is compromised it can cause brain damage and is fatal in 30–50% of cases. The patient who died had been receiving long-term treatment with dimethyl fumarate and had developed a severely low level of lymphocytes, a known side effect of the drug.

Tecfidera was launched in February 2014 by Biogen and was recommended by the National Institute for Health and Care Excellence six months later. In phase III trials, dimethyl fumarate halved the annual relapse rate of relapsing-remitting MS compared with placebo and was more effective than glatiramer.

The case of PML was highlighted by the Pharmacovigilance Risk Assessment Committee (PRAC), part of the European Medicines Agency, at its latest meeting on 3-6 November 2014. PRAC recommended that the case is investigated further.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067150

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Disease Management

    Disease Management

    Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.

    £54.00Buy now
  • Developing Your Prescribing Skills

    Developing Your Prescribing Skills

    Developing Your Prescribing Skills uses case studies, mind maps and feedback from experienced prescribers. It supplies practical advice on the issues facing prescribers in all types of practice.

    £23.00Buy now
  • Workplace Drug Testing

    Workplace Drug Testing

    Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.

    £81.00Buy now
  • Social and Cognitive Pharmacy

    Social and Cognitive Pharmacy

    Social and Cognitive Pharmacy is a practical handbook for learning and teaching sociology and psychology, and applying this to pharmacy practice.

    £33.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.